Literature DB >> 30810426

The colorful landscape of multiple myeloma.

Eli Muchtar1, Morie A Gertz1.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2019        PMID: 30810426      PMCID: PMC7082838          DOI: 10.1080/10428194.2019.1585842

Source DB:  PubMed          Journal:  Leuk Lymphoma        ISSN: 1026-8022


× No keyword cloud information.
  9 in total

1.  CD33 is expressed on plasma cells of a significant number of myeloma patients, and may represent a therapeutic target.

Authors:  N Robillard; S Wuillème; L Lodé; F Magrangeas; S Minvielle; H Avet-Loiseau
Journal:  Leukemia       Date:  2005-11       Impact factor: 11.528

2.  Clinicopathological features of plasmablastic multiple myeloma: a population-based cohort.

Authors:  Hanne E H Møller; Birgitte S Preiss; Per Pedersen; Ida B Kristensen; Charlotte T Hansen; Mikael Frederiksen; Niels Abildgaard; Michael B Møller
Journal:  APMIS       Date:  2015-07-08       Impact factor: 3.205

Review 3.  The multiple myelomas - current concepts in cytogenetic classification and therapy.

Authors:  Shaji K Kumar; S Vincent Rajkumar
Journal:  Nat Rev Clin Oncol       Date:  2018-07       Impact factor: 66.675

4.  Plasmablastic morphology--an independent prognostic factor with clinical and laboratory correlates: Eastern Cooperative Oncology Group (ECOG) myeloma trial E9486 report by the ECOG Myeloma Laboratory Group.

Authors:  P R Greipp; T Leong; J M Bennett; J P Gaillard; B Klein; J A Stewart; M M Oken; N E Kay; B Van Ness; R A Kyle
Journal:  Blood       Date:  1998-04-01       Impact factor: 22.113

5.  Utility of a column-free cell sorting system for separation of plasma cells in multiple myeloma FISH testing in clinical laboratories.

Authors:  Shashirekha Shetty; Marion Siady; Kalyan C Mallempati; Andrew Wilson; Jeff Poarch; Brandon Chandler; Judy Gray; Mohamed E Salama
Journal:  Int J Hematol       Date:  2012-02-11       Impact factor: 2.490

6.  Treatment of multiple myeloma with high-risk cytogenetics: a consensus of the International Myeloma Working Group.

Authors:  Pieter Sonneveld; Hervé Avet-Loiseau; Sagar Lonial; Saad Usmani; David Siegel; Kenneth C Anderson; Wee-Joo Chng; Philippe Moreau; Michel Attal; Robert A Kyle; Jo Caers; Jens Hillengass; Jesús San Miguel; Niels W C J van de Donk; Hermann Einsele; Joan Bladé; Brian G M Durie; Hartmut Goldschmidt; María-Victoria Mateos; Antonio Palumbo; Robert Orlowski
Journal:  Blood       Date:  2016-03-21       Impact factor: 22.113

Review 7.  Interpretation of cytogenetic results in multiple myeloma for clinical practice.

Authors:  A M Rajan; S V Rajkumar
Journal:  Blood Cancer J       Date:  2015-10-30       Impact factor: 11.037

8.  Relationship between initial clinical presentation and the molecular cytogenetic classification of myeloma.

Authors:  A J Greenberg; S V Rajkumar; T M Therneau; P P Singh; A Dispenzieri; S K Kumar
Journal:  Leukemia       Date:  2013-09-05       Impact factor: 11.528

Review 9.  Immunotherapy: A Novel Era of Promising Treatments for Multiple Myeloma.

Authors:  Maria Castella; Carlos Fernández de Larrea; Beatriz Martín-Antonio
Journal:  Int J Mol Sci       Date:  2018-11-15       Impact factor: 5.923

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.